Amygdalin isolated from Amygdalus mongolica protects against hepatic fibrosis in rats

1. S. L. Friedman, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J. Bio. Chem.4 (2000) 2247–2250; https://doi.org/10.1074/jbc.275.4.224710.1074/jbc.275.4.224710644669Search in Google Scholar

2. R. T. Hong, J. M. Xu and Q. Mei, Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats, World J. Gastroenterol.12 (2009) 1452–1458; https://doi.org/10.3748/wjg.15.145210.3748/wjg.15.1452266912419322917Search in Google Scholar

3. M. Pinzani and K. Rombouts, Liver fibrosis: from the bench to clinical targets, Dig. Liver Dis.4 (2004) 231–242; https://doi.org/10.1016/j.dld.2004.01.00310.1016/j.dld.2004.01.00315115333Search in Google Scholar

4. T. Christian, L. F. Scott, S. Detlef and P. Massimo, Hepatic fibrosis: Concept to treatment, J. Hepatol.1 (2015) S15-24; https://doi.org/10.1016/j.jhep.2015.02.03910.1016/j.jhep.2015.02.03925920084Search in Google Scholar

5. H. K. Du, F. C. Song, X. Zhou, H. Li and J. P. Zhang, Effect of amygdalin on serum proteinic bio-marker in pulmonary fibrosis of bleomycin-induced rat, Chin. J. Ind. Hygi. Occup. Dis.4 (2010) 260–263.Search in Google Scholar

6. X. M. Li, J. H. Peng, Z. L. Sun, H. J. Tian, X. H. Duan, L. Liu, X. Ma, Q. Feng, P. Liu and Y. Y. Hu, Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways, Acta. Pharmacol. Sin.6 (2016) 783–793; https://doi.org/10.1038/aps.2016.3510.1038/aps.2016.35495476727133300Search in Google Scholar

7. E. Aghadavod, Amygdalin; is it an anticancer and antitumor agent? Epidemiol. Prev.2 (2016) e22.Search in Google Scholar

8. J. Q. Liu, D. Y. Wang and L. Wang, Influences of treatment methods on water absorption of Prunus mongolica seeds and its seedling growth, Chin. For. Sci. Technol.21 (2010) 38–41.Search in Google Scholar

9. Y. Q. Ma, Flora of Inner Mongolia, Vol. 3, Hohhot: Inner Mongolia People’s Publishing House, 1989, p. 132.Search in Google Scholar

10. S. L. Shi, Y. C. Bai, H. B. Zhou and S. F. Niu, Extraction and determination of content of polysaccharides in Amygdalus mongolica, Lishizhen Med. Mater. Med. Res.24 (2013) 257–258.Search in Google Scholar

11. K. Su, S. L. Shi, D. H. Zheng and J. X. Li, Determination of alpha tocopherol content in Amygdalus mongolica by HPLC, Chin. J. Exp. Trad. Med. Form.19 (2013) 70–72.Search in Google Scholar

12. J. Q. Guo, W. Z. Wu, M. X. Sheng, S. L. Yang and J. M. Tan, Amygdalin inhibits renal fibrosis in chronic kidney disease, Mol. Med. Rep.5 (2013) 1453–1457; https://doi.org/10.3892/mmr.2013.139110.3892/mmr.2013.139123525378Search in Google Scholar

13. H. H. Luo, F. Zhao, F. X. Zhang and L. Ni, Influence of amygdalin on PDG, IGF and PDGFR expression in HSC-T6 cells, Exp. Ther. Med.15 (2018) 3693–3698; https://doi.org/10.3892/etm.2018.588610.3892/etm.2018.5886584410229556259Search in Google Scholar

14. Y. S. Zhao, P. S. Wu, H. W. Zhang, X. H. Cheng, S. L. Shi, Q. L. Liu and H. B. Zhou, Studies on dose-effect relationship of n-butanol extracts of Amygdalus mongolica on reducing blood lipid and its chemical constituents, Sci. Technol. Food. Ind.38 (2017) 348–352.Search in Google Scholar

15. J. J. Jin, M. Zhong, S. M. Yu and L. Jie, Effect of water extract of Cudrania cochinchinensis on liver fibrosis rat models induced by carbon tetrachloride, Chin. J. Exp. Trad. Med. Formu.22 (2012) 258–262.Search in Google Scholar

16. M. P. Ren, Y. Liu, H. Li, M. H. Liu, H. Zhang and J. B. Wu, Study on Aralia saponins in preventing CCL4 induced liver fibrosis in rats, J. Shenyang Pharm. Univ.12 (2013) 958–960.Search in Google Scholar

17. S. F. Zhao and Q. C. Kan, Protective effects of Liuweiwuling pian on hepatic fibrosis induced by carbon tetrachloride in rats, Chin. Pharm. Bull.6 (2011) 872–875; https://doi.org/10.3969/j.issn.1001-1978.2011.06.031Search in Google Scholar

18. G. W. Newton, E. S. Schmidt, J. P. Lewis, E. Conn and R. Lawrence, Amygdalin toxicity studies in rats predict chronic cyanide poisoning in humans, West J. Med.2 (1981) 97–103; https://doi.org/10.1620/tjem.133.48110.1620/tjem.133.4817256742Search in Google Scholar

19. Y. A. Lee and S. L. Friedman, Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C? Antiviral. Res.107 (2014) 23–30; https://doi.org/10.1016/j.antiviral.2014.03.01210.1016/j.antiviral.2014.03.012405074424726738Search in Google Scholar

20. J. P. Li, Y. Gao, S. F. Chu, Z. Zhang, C. Y. Xia, Z. Mou, X. Y. Song, W. B. He, X. F. Guo and N. H. Chen, Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl₄-induced hepatic fibrosis, Acta. Pharmacol. Sin.8 (2014) 1031–1044; https://doi.org/10.1038/aps.2014.4110.1038/aps.2014.41412571124976156Search in Google Scholar

21. S. Yamada and C. Hirayama, Clinical significance of serum hydroxyproline-containing peptides with special reference to hyproprotein, Eur. J. Clin. Invest.2 (2010) 129–133; https://doi.org/10.1111/j.1365-2362.1983.tb00077.x10.1111/j.1365-2362.1983.tb00077.x6409636Search in Google Scholar

22. G. G. Xu, C. Y. Luo, S. M. Wu and C. L. Wang, The relationship between staging of hepatic fibrosis and the levels of serum biochemistry, Hepatobiliary Pancreat, Dis. Int.2 (2002) 246–248; https://doi.org/CNKI:SUN:GJGD.0.2002-02-019Search in Google Scholar

23. S. P. You, J. Zhao, L. Ma, M. Tudimat, S. L. Zhang and T. Liu, Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats, J. Pharm. Sci.1 (2015) 1–13; https://doi.org/10.1186/s40199-015-0135-410.1186/s40199-015-0135-4467372126646297Search in Google Scholar

24. J Liu, J. Y. Wang and Y. Lu, Serum fibrosis markers in diagnosing liver fibrosis, Chin. J. Intern. Med.6 (2006) 475–477.Search in Google Scholar

25. S. Clichici, C. Catoi, T. Mocan, A. Filip, C. Login, A. L. Nagy, D. Doina, N. Decea, C. Gherman, R. Moldovan and A. Muresan, Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis, Acta Physiol. Hung.98 (2011) 195–204; https://10.1556/APhysiol.98.2011.2.1110.1556/APhysiol.98.2011.2.1121616778Search in Google Scholar

26. H. B. Tan, Q. He, R. G. Li, and F. F. Lei and X. Lei, Trillin Reduces Liver Chronic Inflammation and Fibrosis in Carbon Tetrachloride (CCl₄) Induced Liver Injury in Mice, Immunol. Commun.45 (2016) 371–382; https://doi.org/10.3109/08820139.2015.113793510.3109/08820139.2015.113793527219527Search in Google Scholar

27. T. A. Wynn, Cellular and molecular mechanisms of fibrosis, J. Pathol. 2 (2010) 199–210; https://doi.org/10.1002/path.227710.1002/path.2277269332918161745Search in Google Scholar

28. C. J. Parsons, T. Motoki and R. A. Rippe, Molecular mechanisms of hepatic fibrogenesis, J. Gastroenterol. Hepatol.1 (2007) S79–84; https://doi.org/10.1111/j.1440-1746.2006.04659.x10.1111/j.1440-1746.2006.04659.x17567474Search in Google Scholar

29. Y. M. Yang and E. Seki, TNFα in liver fibrosis, Curr. Pathobiol. Rep.4 (2015) 253–261; https://doi.org/10.1007/s40139-015-0093-z10.1007/s40139-015-0093-z469360226726307Search in Google Scholar

30. A. Mehra and J. L. Wrana, TGF-β and the Smad signal transduction pathway, Biochem. Cell Biol.5 (2002) 605–622; https://doi.org/10.1139/o02-16110.1139/o02-16112440701Search in Google Scholar

31. F. Y. Xu, C. W. Liu, D. D. Zhou and L. Zhang, TGF/SMAD Pathways and its regulation in hepatic fibrosis, J. Histochem. Cytochem. 3 (2016) 157–167; https://doi.org/10.1369/002215541562768110.1369/0022155415627681481080026747705Search in Google Scholar